⌘K
t
| TIDM | AMS |
| Share Price | GBX 279.500.18% |
| Market Cap | £613.79m |
Advanced Medical Solutions Group plc (AMS) published a block admission return on 9 September 2025, detailing share movements under its employee share schemes for the period from 6 March 2025 to 5 September 2025. During this period, AMS allotted a total of 156,216 ordinary shares across its Deferred Share Bonus Scheme (1,739), Company Share Option Plan (41,970), Unapproved Executive Share Option Scheme (82,562), Long Term Incentive Plan (13,886), and Deferred Annual Bonus Scheme (16,059). As of 5 September 2025, 87,573 ordinary shares remained unallotted under the Company Share Option Plan, 84,541 under the Unapproved Executive Share Option Scheme, and 229,762 under the Deferred Annual Bonus Scheme.
| Date | 9 Sept 2025 |
| Time | 18:28:54 |
| Category | Capital structure |
| ID | 6753Y |
|
|
9 September 2025 |
("AMS", the "Company" or the "Group")
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:
|
Name of applicant: |
Advanced Medical Solutions Group plc |
|||
|
Name of scheme: |
Block Scheme for: 1. Deferred Share Bonus Scheme 2. Enterprise Management Incentive Scheme 3. Company Share Option Plan 4. Unapproved Executive Share Option Scheme 5. Long Term Incentive Plan 6. Deferred Annual Bonus Scheme |
|||
|
Period of return: |
From: |
6 March 2025 |
To: |
5 September 2025 |
|
Balance of unallotted securities under scheme(s) from previous return: |
1. 1,739 2. Nil 3. 129,543 4. 167,103 5. 13,886 6. 245,821 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
1. Nil 2. Nil 3. Nil 4. Nil 5. Nil 6. Nil |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period: |
1. 1,739 2. Nil 3. 41,970 4. 82,562 5. 13,886 6. 16,059 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
1. Nil 2. Nil 3. 87,573 4. 84,541 5. Nil 6. 229,762 |
|||
|
Number and class of securities originally listed and the date of admission: |
4,476,264 ordinary shares of 5p each on 6 September 2018.
|
|||
|
Name of contact: |
Owen Bromley |
|
Telephone number of contact: |
01606 545514 |
For further information, please visit www.admedsol.com or contact:
|
Advanced Medical Solutions Group plc |
Tel: +44 (0) 1606 545508 |
|
Chris Meredith, Chief Executive Officer Eddie Johnson, Chief Financial Officer Michael King, Investor Relations |
|
|
|
|
|
Optimum Strategic Communications |
Tel: +44 (0) 20 4566 8543 |
|
Mary Clark / Nick Bastin / Isabelle Abdou |
|
|
|
|
|
Investec Bank PLC (NOMAD & Broker) |
Tel: +44 (0) 20 7597 5970 |
|
Gary Clarence / David Anderson |
|
|
|
|
|
Berenberg (Joint Broker) |
Tel: +44 (0) 20 3207 7800 |
|
Toby Flaux / Detlir Elezi / Yasmina Benchekroun |
|
|
|
|